These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 28794294

  • 21. Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy.
    Racca MA, Novoa PA, Rodríguez I, Della Vedova AB, Pellizas CG, Demarchi M, Donadio AC.
    Transpl Int; 2015 Jan; 28(1):71-8. PubMed ID: 25179305
    [Abstract] [Full Text] [Related]

  • 22. Distinctive expression signatures of serum microRNAs in ischaemic stroke and transient ischaemic attack patients.
    Wu J, Fan CL, Ma LJ, Liu T, Wang C, Song JX, Lv QS, Pan H, Zhang CN, Wang JJ.
    Thromb Haemost; 2017 May 03; 117(5):992-1001. PubMed ID: 28251236
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy.
    Neumann A, Napp LC, Kleeberger JA, Benecke N, Pfanne A, Haverich A, Thum T, Bara C.
    Transplantation; 2017 Jan 03; 101(1):e26-e33. PubMed ID: 27653298
    [Abstract] [Full Text] [Related]

  • 24. Increased urinary cystatin C level is associated with interstitial fibrosis and tubular atrophy in kidney allograft recipients.
    Mendes Mde F, Salgado JV, de Ribamar Lima J, Ferreira TC, Silva GE, Filho NS.
    Clin Biochem; 2015 May 03; 48(7-8):546-9. PubMed ID: 25746149
    [Abstract] [Full Text] [Related]

  • 25. Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy.
    Nogare AL, Veronese FV, Carpio VN, Montenegro RM, Pedroso JA, Pegas KL, Gonçalves LF, Manfro RC.
    BMC Nephrol; 2015 Feb 13; 16():19. PubMed ID: 25884518
    [Abstract] [Full Text] [Related]

  • 26. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
    Yao Q, Wang X, He W, Song Z, Wang B, Zhang J, Qin Q.
    Endocrine; 2019 Jul 13; 65(1):102-109. PubMed ID: 30949910
    [Abstract] [Full Text] [Related]

  • 27. Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia.
    Liu K, Xuekelati S, Zhang Y, Yin Y, Li Y, Chai R, Li X, Peng Y, Wu J, Guo X.
    BMC Cardiovasc Disord; 2017 Jun 20; 17(1):163. PubMed ID: 28633641
    [Abstract] [Full Text] [Related]

  • 28. Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis.
    Wang C, Yang S, Liu CM, Jiang TT, Chen ZL, Tu HH, Mao LG, Li ZJ, Li JC.
    Tuberculosis (Edinb); 2018 Jan 20; 108():26-34. PubMed ID: 29523324
    [Abstract] [Full Text] [Related]

  • 29. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.
    Prabhakar P, Chandra SR, Christopher R.
    Age Ageing; 2017 Sep 01; 46(5):861-864. PubMed ID: 28633305
    [Abstract] [Full Text] [Related]

  • 30. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C, Dalla Costa E, Lebelt D, Ferrante V, Canali E, Ceciliani F, Stucke D, Minero M.
    Animal; 2018 Feb 01; 12(2):366-375. PubMed ID: 28689512
    [Abstract] [Full Text] [Related]

  • 31. Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
    Schauerte C, Hübner A, Rong S, Wang S, Shushakova N, Mengel M, Dettling A, Bang C, Scherf K, Koelling M, Melk A, Haller H, Thum T, Lorenzen JM.
    Kidney Int; 2017 Sep 01; 92(3):646-656. PubMed ID: 28396121
    [Abstract] [Full Text] [Related]

  • 32. Association between Circulating MicroRNAs (miR-21-5p, miR-20a-5p, miR-29b-3p, miR-126-3p and miR-101-3p) and Chronic Allograft Dysfunction in Renal Transplant Recipients.
    Chen YJ, Hsu CT, Tsai SF, Chen CH.
    Int J Mol Sci; 2022 Oct 14; 23(20):. PubMed ID: 36293110
    [Abstract] [Full Text] [Related]

  • 33. Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy.
    Singh N, Heggermont W, Fieuws S, Vanhaecke J, Van Cleemput J, De Geest B.
    J Heart Lung Transplant; 2015 Nov 14; 34(11):1376-84. PubMed ID: 26198441
    [Abstract] [Full Text] [Related]

  • 34. A circulating exosomal microRNA panel as a novel biomarker for monitoring post-transplant renal graft function.
    Chen Y, Han X, Sun Y, He X, Xue D.
    J Cell Mol Med; 2020 Oct 14; 24(20):12154-12163. PubMed ID: 32918330
    [Abstract] [Full Text] [Related]

  • 35. Expression of microRNA-129-2-3p and microRNA-935 in plasma and brain tissue of human refractory epilepsy.
    Sun Y, Wang X, Wang Z, Zhang Y, Che N, Luo X, Tan Z, Sun X, Li X, Yang K, Wang G, Luan L, Liu Y, Zheng X, Wei M, Cheng H, Yin J.
    Epilepsy Res; 2016 Nov 14; 127():276-283. PubMed ID: 27689807
    [Abstract] [Full Text] [Related]

  • 36. Lower Circulating Cytotoxic T-Cell Frequency and Higher Intragraft Granzyme-B Expression Are Associated with Inflammatory Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Recipients.
    Yadav B, Prasad N, Agrawal V, Agarwal V, Jain M.
    Medicina (Kaunas); 2023 Jun 20; 59(6):. PubMed ID: 37374379
    [Abstract] [Full Text] [Related]

  • 37. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M.
    Curr Opin Nephrol Hypertens; 2014 May 20; 23(3):245-50. PubMed ID: 24626060
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis.
    Ben-Dov IZ, Muthukumar T, Morozov P, Mueller FB, Tuschl T, Suthanthiran M.
    Transplantation; 2012 Dec 15; 94(11):1086-94. PubMed ID: 23131772
    [Abstract] [Full Text] [Related]

  • 39. Differential MicroRNA Expressions in Human Peripheral Blood Mononuclear Cells Are Predictive of Renal Allograft Function.
    Li F, Qian W, Quan X, Yang H, Zhao G, Wei L.
    Transplant Proc; 2019 Apr 15; 51(3):715-721. PubMed ID: 30979455
    [Abstract] [Full Text] [Related]

  • 40. Free microRNA levels in plasma distinguish T-cell mediated rejection from stable graft function after kidney transplantation.
    Matz M, Lorkowski C, Fabritius K, Durek P, Wu K, Rudolph B, Neumayer HH, Mashreghi MF, Budde K.
    Transpl Immunol; 2016 Nov 15; 39():52-59. PubMed ID: 27663089
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.